Data & Technology

Longitudinal patient-level data answer pressing questions about patient safety, outcomes and medication acceptance

Converging the processes and data from EHRs and from the electronic data-capture (EDC) of the clinical research environment could change the paradigm of drug development and safety

Old software and poor data quality cause both revenue losses and extra expense to reconcile claims. Will serialized packages provide an eventual cure?

With limited IT resources, the company is rolling out one business-intelligence application after another

Enterprise resource planning

Pharma industry involvement in the supply-chain transaction service remains low

Usually associated with manufacturing or laboratory processes, quality systems can improve post-marketing compliance efforts

Industry survey shows strengths and weaknesses of current IT support of supply chains

How to correlate plant performance to business performance

With new serialization-software release, Systech promotes ‘near-line’ applications

A fast-growing market supports more, and more comprehensive, data services

Deloitte’s annual study of information security trends finds gaping holes in network security

New IDC study finds that Oracle is the now the top life-sciences IT vendor; meanwhile, are there ‘demons’ in the pharma supply chain?

The marketplace requirements for sales force structures are changing faster than the industry is evolving

War-gaming analyst picks the drug distributor over Microsoft, Allscripts and other EMR players

New parent, Take Solutions, adds biopharma application expertise

Can software tools help manage business partnerships?

Integrated offering target business intelligence applications

WAM Systems and Ortems link up for joint IT solutions

War-gaming analyst picks the drug distributor over Microsoft, Allscripts and other EMR players

Meanwhile, Ziment offers tools for assessing physician communications

Innovative middleware lowers the administrative burden of managing large databases

American Recovery and Reinvestment Act allocates $18 billion for HIT

American Recovery and Reinvestment Act allocates $18 billion for HIT

Expect a flood of product-liability suits in the aftermath of Wyeth vs. Levine